Speaker illustration

Doctor Peter Ueda

Karolinska Institute, Stockholm (Sweden)

Assistant Professor in clinical epidemiology at Karolinska Institutet and junior physician at the Department of Endocrinology, Karolinska University Hospital and Center for Diabetes, Stockholm Region. Obtained medical degree and a PhD in epidemiology at Karolinska Institutet and was a post-doctoral researcher at Harvard TH Chan School of Public Health. Current research focus include pharmacoepidemiological studies on glucose-lowering drugs, cholesterol-lowering drugs and dual antiplatelet therapy as well as cardiovascular risk prediction.

Take-home messages: glucose-lowering medication after myocardial infarction in hospital and after discharge.

Event: ESC Congress 2022

Topic: Risk Factors and Prevention

Session: What the cardiologist must know: glucose-lowering medication after myocardial infarction in hospital and after discharge

Thumbnail

External validation of the DAPT score in nationwide real-world data: ischemic and bleeding events following coronary stent implantation

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: The value of risk scores for assessment in acute coronary syndrome

Thumbnail

Cohort Study of Serious Adverse Events with Sodium-Glucose Cotransporter 2 Inhibitors

Event: ESC Congress 2018

Topic: Antidiabetic Pharmacotherapy

Session: Late Breaking Pharmacological Science

Thumbnail

Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England

Event: ESC CONGRESS 2017

Topic: Epidemiology, lipids

Session: Best Posters in prevention

Thumbnail

ESC 365 is supported by

logo Novo Nordisk